Biotech Startup Prilenia Picked up $43 Million in a Series B Funding Round

What is Prilenia? Prilenia is a biotechnology services provider. What does Prilenia do? The company develops treatments for neurodegenerative and neurodevelopmental disorders. Who owns Prilenia? Michael R Hayden founded Prilenia in 2018. How much has Prilenia raised? The company picked up $43 million in a Series B funding round that brings the company’s total financing […]

Click Therapeutics raised $52 million in a Series B funding round

Click Therapeutics is a regulated Software as a Medical Device (SaMD)-focused biotechnology company. They raised a total of $911 million.

Previous page Next page